Amarin Corporation PLC Acc.21 From Bench to Bedside and Beyond - Corporate Call Transcript
Welcome to Amarin Corporation's American College of Cardiology's 70th Annual Scientific session discussion where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, May 17, 2021. I would now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.
Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the American College of Cardiology's 70th Annual Scientific session. We are honored today to be able to bring to you for your consideration, the opinions of an esteemed group of clinicians and scientists. Opinions expressed by the clinicians and scientists on this webcast are theirs alone. They have neither been scripted nor previewed by Amarin. While Amarin values their perspective, we may not necessarily agree with their
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
